{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:40:37Z","timestamp":1776922837832,"version":"3.51.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J01628"],"award-info":[{"award-number":["2023J01628"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04739-z","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:47:05Z","timestamp":1773668825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nonlinear associations of remnant cholesterol\/high-density lipoprotein cholesterol ratio with the risk of metabolic-associated fatty liver disease: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Lizhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-e","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"1","key":"4739_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"9","key":"4739_CR2","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan KE, Koh TJL, Tang ASP, Quek J, Yong JN, Tay P, et al. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. J Clin Endocrinol Metab. 2022;107(9):2691\u2013700.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4739_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1210\/clinem\/dgab641","volume":"107","author":"Y Liang","year":"2022","unstructured":"Liang Y, Chen H, Liu Y, Hou X, Wei L, Bao Y, et al. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. J Clin Endocrinol Metab. 2022;107(1):88\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4739_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","volume":"79","author":"P Sangro","year":"2023","unstructured":"Sangro P, de la Torre Al\u00e1ez M, Sangro B, D\u2019Avola D. Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. J Physiol Biochem. 2023;79(4):869\u201379.","journal-title":"J Physiol Biochem"},{"issue":"1S Suppl 1","key":"4739_CR5","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1097\/MEG.0000000000002335","volume":"33","author":"J C\u00f3rdova-Gallardo","year":"2021","unstructured":"C\u00f3rdova-Gallardo J, Keaveny AP, Qi X, M\u00e9ndez-S\u00e1nchez N. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problems. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e84\u201393.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"4739_CR6","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364.","journal-title":"J Hepatol"},{"issue":"4","key":"4739_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim D, Kim WR. Nonobese Fatty Liver Disease. Clin Gastroenterol Hepatol. 2017;15(4):474\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"4739_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999\u2013e20141.","journal-title":"Gastroenterology"},{"issue":"7","key":"4739_CR9","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.3390\/ijms25073694","volume":"25","author":"JP De C\u00f3l","year":"2024","unstructured":"De C\u00f3l JP, de Lima EP, Pompeu FM, Cressoni Ara\u00fajo A, de Alvares Goulart R, Bechara MD, et al. Underlying Mechanisms behind the Brain-Gut-Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. Int J Mol Sci. 2024;25(7):3694.","journal-title":"Int J Mol Sci"},{"issue":"27","key":"4739_CR10","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","volume":"24","author":"YL Fang","year":"2018","unstructured":"Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From two hit theory to multiple hit model. World J Gastroenterol. 2018;24(27):2974\u201383.","journal-title":"World J Gastroenterol"},{"key":"4739_CR11","doi-asserted-by":"publisher","first-page":"154955","DOI":"10.1016\/j.metabol.2021.154955","volume":"127","author":"Z Liu","year":"2022","unstructured":"Liu Z, Lin C, Suo C, Zhao R, Jin L, Zhang T, et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism. 2022;127:154955.","journal-title":"Metabolism"},{"key":"4739_CR12","doi-asserted-by":"crossref","unstructured":"Spengler EK, Loomba R. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Mayo Clin Proc. 2015;90(9): 1233-46.","DOI":"10.1016\/j.mayocp.2015.06.013"},{"issue":"11","key":"4739_CR13","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1161\/ATVBAHA.116.308305","volume":"36","author":"A Varbo","year":"2016","unstructured":"Varbo A, Nordestgaard BG. Remnant Cholesterol and Triglyceride-Rich Lipoproteins in Atherosclerosis Progression and Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2016;36(11):2133\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"4739_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2337\/dc22-1550","volume":"46","author":"JH Huh","year":"2023","unstructured":"Huh JH, Roh E, Lee SJ, Ihm SH, Han KD, Kang JG. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care. 2023;46(2):305\u201312.","journal-title":"Diabetes Care"},{"issue":"1","key":"4739_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12944-024-02148-3","volume":"23","author":"H Lin","year":"2024","unstructured":"Lin H, Xu J, Teng C. Correlation between remnant cholesterol and hyperuricemia in patients with type 2 diabetes mellitus: a cross-sectional study. Lipids Health Dis. 2024;23(1):155.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4739_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s40001-023-01369-z","volume":"28","author":"J Jin","year":"2023","unstructured":"Jin J, Hu X, Francois M, Zeng P, Wang W, Yu B, et al. Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study. Eur J Med Res. 2023;28(1):420.","journal-title":"Eur J Med Res"},{"issue":"1","key":"4739_CR17","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1038\/s41598-024-55282-4","volume":"14","author":"S Wang","year":"2024","unstructured":"Wang S, Zhang Q, Qin B. Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease. Sci Rep. 2024;14(1):4596.","journal-title":"Sci Rep"},{"key":"4739_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1265\/ehpm.23-00289","volume":"29","author":"L Liu","year":"2024","unstructured":"Liu L, Wang C, Hu Z, Deng S, Yang S, Zhu X, et al. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study. Environ Health Prev Med. 2024;29:5.","journal-title":"Environ Health Prev Med"},{"issue":"6","key":"4739_CR19","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.jhepr.2020.100150","volume":"2","author":"J Chin","year":"2020","unstructured":"Chin J, Mori TA, Adams LA, Beilin LJ, Huang RC, Olynyk JK, et al. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. JHEP Rep. 2020;2(6):100150.","journal-title":"JHEP Rep"},{"issue":"8","key":"4739_CR20","doi-asserted-by":"publisher","first-page":"e3295","DOI":"10.1210\/clinem\/dgac283","volume":"107","author":"H Huang","year":"2022","unstructured":"Huang H, Guo Y, Liu Z, Zeng Y, Chen Y, Xu C. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease. J Clin Endocrinol Metab. 2022;107(8):e3295\u2013303.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4739_CR21","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1210\/clinem\/dgad272","volume":"108","author":"H Huang","year":"2023","unstructured":"Huang H, Xie J, Zeng Y, Liu Z, Miao M, Xu L, et al. Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2023;108(11):2907\u201315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4739_CR22","doi-asserted-by":"publisher","first-page":"e069440","DOI":"10.1136\/bmjopen-2022-069440","volume":"13","author":"Y Miao","year":"2023","unstructured":"Miao Y, Tao H. Association between remnant lipoprotein cholesterol levels and risk of non-alcoholic fatty liver disease in non-obese populations: a Chinese longitudinal prospective cohort study. BMJ Open. 2023;13(5):e069440.","journal-title":"BMJ Open"},{"key":"4739_CR23","doi-asserted-by":"publisher","first-page":"110733","DOI":"10.1016\/j.diabres.2023.110733","volume":"201","author":"J Chen","year":"2023","unstructured":"Chen J, Su Y, Su X, Luo F. Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease. Diabetes Res Clin Pract. 2023;201:110733.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"4739_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12944-021-01573-y","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou Y, Lan J, Zhong Y, Yang S, Zhang H, Xie G. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. Lipids Health Dis. 2021;20(1):139.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4739_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12967-022-03470-z","volume":"20","author":"G Sheng","year":"2022","unstructured":"Sheng G, Kuang M, Yang R, Zhong Y, Zhang S, Zou Y. Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population. J Transl Med. 2022;20(1):266.","journal-title":"J Transl Med"},{"key":"4739_CR26","doi-asserted-by":"publisher","first-page":"1514067","DOI":"10.3389\/fendo.2025.1514067","volume":"16","author":"Y Tai","year":"2025","unstructured":"Tai Y, Chen B, Kong Y, Wang X. Association between RC\/HDL-C and hyperuricemia in adults: evidence from NHANES 2005\u20132018. Front Endocrinol (Lausanne). 2025;16:1514067.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4739_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-023-02103-z","volume":"23","author":"M Li","year":"2024","unstructured":"Li M, Zhang W, Zhang M, Li L, Wang D, Yan G, et al. Nonlinear relationship between untraditional lipid parameters and the risk of prediabetes: a large retrospective study based on Chinese adults. Cardiovasc Diabetol. 2024;23(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"4739_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12902-024-01764-5","volume":"24","author":"S Lu","year":"2024","unstructured":"Lu S, Kuang M, Qiu J, Li W, Zhang M, Sheng G, et al. Lipids as the link between central obesity and diabetes: perspectives from mediation analysis. BMC Endocr Disord. 2024;24(1):229.","journal-title":"BMC Endocr Disord"},{"key":"4739_CR29","doi-asserted-by":"crossref","unstructured":"Wang LL, Xu ZX, Sun BQ, Liu J, Liu XL, Liu D. Sex Differences in the Relationship Between Lipid Ratios and the Risk of Carotid Plaque. Angiology. 2025;33197251316624.","DOI":"10.1177\/00033197251316624"},{"issue":"1","key":"4739_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12944-020-01336-1","volume":"19","author":"WS Yang","year":"2020","unstructured":"Yang WS, Li R, Shen YQ, Wang XC, Liu QJ, Wang HY, et al. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Lipids Health Dis. 2020;19(1):160.","journal-title":"Lipids Health Dis"},{"key":"4739_CR31","doi-asserted-by":"publisher","first-page":"1427138","DOI":"10.3389\/fmed.2024.1427138","volume":"11","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, Hu W, Wang Y, Li J, Yang L, Yu S, et al. Association between RC\/HDL-C ratio and risk of non-alcoholic fatty liver disease in the United States. Front Med (Lausanne). 2024;11:1427138.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"4739_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12967-023-04047-0","volume":"21","author":"S Lu","year":"2023","unstructured":"Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, et al. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. J Transl Med. 2023;21(1):192.","journal-title":"J Transl Med"},{"issue":"5","key":"4739_CR33","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12072-023-10568-z","volume":"17","author":"K Vaz","year":"2023","unstructured":"Vaz K, Clayton-Chubb D, Majeed A, Lubel J, Simmons D, Kemp W, et al. Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes. Hepatol Int. 2023;17(5):1082\u201397.","journal-title":"Hepatol Int"},{"issue":"1","key":"4739_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"1","key":"4739_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s40001-025-02373-1","volume":"30","author":"R Zhu","year":"2025","unstructured":"Zhu R, Xu C, Jiang S, Xia J, Wu B, Zhang S, et al. Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China. Eur J Med Res. 2025;30(1):137.","journal-title":"Eur J Med Res"},{"issue":"8","key":"4739_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(8):739\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"4739_CR37","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/ajg.2012.314","volume":"107","author":"YM Kwon","year":"2012","unstructured":"Kwon YM, Oh SW, Hwang S, sik, Lee C, Kwon H, Chung GE. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107(12):1852\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"47","key":"4739_CR38","doi-asserted-by":"publisher","first-page":"17932","DOI":"10.3748\/wjg.v20.i47.17932","volume":"20","author":"RN Feng","year":"2014","unstructured":"Feng RN, Du SS, Wang C, Li YC, Liu LY, Guo FC, et al. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol. 2014;20(47):17932\u201340.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4739_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12944-020-01419-z","volume":"19","author":"Y Zou","year":"2020","unstructured":"Zou Y, Zhong L, Hu C, Sheng G. Association between the alanine aminotransferase\/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids Health Dis. 2020;19(1):245.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4739_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12876-021-01824-3","volume":"21","author":"G Sheng","year":"2021","unstructured":"Sheng G, Xie Q, Wang R, Hu C, Zhong M, Zou Y. Waist-to-height ratio and non-alcoholic fatty liver disease in adults. BMC Gastroenterol. 2021;21(1):239.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"4739_CR41","doi-asserted-by":"publisher","first-page":"101807","DOI":"10.1016\/j.clinre.2021.101807","volume":"46","author":"A Cordeiro","year":"2022","unstructured":"Cordeiro A, Ribamar A, Ramalho A. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19. Clin Res Hepatol Gastroenterol. 2022;46(3):101807.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"8","key":"4739_CR42","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/ajg.2013.104","volume":"108","author":"C Xu","year":"2013","unstructured":"Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study. Am J Gastroenterol. 2013;108(8):1299\u2013304.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"4739_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12876-022-02216-x","volume":"22","author":"Y Zou","year":"2022","unstructured":"Zou Y, Hu C, Kuang M, Chai Y. Remnant cholesterol\/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease. BMC Gastroenterol. 2022;22(1):134.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"4739_CR44","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada P, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C, Valverde \u00c1M. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 2020;11(9):802.","journal-title":"Cell Death Dis"},{"key":"4739_CR45","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3389\/fphys.2020.00873","volume":"11","author":"E Pandey","year":"2020","unstructured":"Pandey E, Nour AS, Harris EN. Prominent Receptors of Liver Sinusoidal Endothelial Cells in Liver Homeostasis and Disease. Front Physiol. 2020;11:873.","journal-title":"Front Physiol"},{"issue":"6","key":"4739_CR46","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1499-3872(13)60099-5","volume":"12","author":"Y Qiu","year":"2013","unstructured":"Qiu Y, Liu S, Chen HT, Yu CH, Teng XD, Yao HT, et al. Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2013;12(6):630\u20136.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"4739_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.plefa.2016.05.005","volume":"138","author":"AG Jay","year":"2018","unstructured":"Jay AG, Hamilton JA. The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL. Prostaglandins Leukot Essent Fat Acids. 2018;138:64\u201370.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"23","key":"4739_CR48","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","volume":"64","author":"RS Rosenson","year":"2014","unstructured":"Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64(23):2525\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"4739_CR49","doi-asserted-by":"publisher","first-page":"17514","DOI":"10.3390\/ijms242417514","volume":"24","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Zhou Y, Wang D, Huang Z, Xiao X, Zheng Q, et al. Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD). Int J Mol Sci. 2023;24(24):17514.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4739_CR50","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","volume":"128","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation. 2013;128(12):1298\u2013309.","journal-title":"Circulation"},{"issue":"38","key":"4739_CR51","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","volume":"16","author":"G Tarantino","year":"2010","unstructured":"Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance. World J Gastroenterol. 2010;16(38):4773\u201383.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4739_CR52","first-page":"167","volume":"27","author":"D Lucero","year":"2015","unstructured":"Lucero D, Miksztowicz V, Macri V, L\u00f3pez GH, Friedman S, Berg G, et al. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-\u03b1. Clin Investig Arterioscler. 2015;27(4):167\u201374.","journal-title":"Clin Investig Arterioscler"},{"key":"4739_CR53","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","volume":"42","author":"A Deprince","year":"2020","unstructured":"Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020;42:101092.","journal-title":"Mol Metab"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04739-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:51:34Z","timestamp":1776919894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4739"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04739-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008) and was approved by Ethics Committee of Fujian Medical University (ethics number 2014096). Participants gave informed consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}